Innovative MRI to Localize the Epileptic Zone
ConditionEpilepsy, Temporal Lobe
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorUniversity Hospital, Grenoble
About this trial
The goal of EPI-CATCHER is to outline the clinical potential of multiparametric quantitative MRI (mqMRI) and of GABA-edited magnetic resonance spectroscopy (GABA-MRS), combined with machine learning tools, as imaging biomarkers to localize and delineate the EZ.
Eligibility criteria
Qualifiers
Patient group
Patients aged 18-65 years,
Patients with drug-resistant focal epilepsy,
Patients with MTLE suspicion, with normal MRI or hippocampal sclerosis, and candidate for surgery,
Disqualifiers
Patient group
Patient without social security system
Inability or unwillingness of the individual to provide written informed consent, according to national regulations.
Impossibility of collecting information on exposure (subjects recently arrived in France, foreign language, etc.),
Trial design
Treatments tested in this trial
- mqMRI and GABA-MRS
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
University Hospital, Grenoble
Lead sponsor
University Grenoble Alps
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov